M. Crespo

发表

A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients

J. Castellví, Carla Serra-Peinado, J. Grau-Expósito, 2017, mBio.

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2021, BMC Women's Health.

Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes.

M. Crespo, J. Pineda, A. Rivero, 2015, Antiviral research.

Non-tuberculous mycobacteria in the sputum of HIV-infected patients: infection or colonization?

A. Curran, I. Ocaña, E. Ribera, 2009, International journal of STD & AIDS.

Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection

C. Tural, J. Mallolas, M. Crespo, 2017, Hepatology.

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

R. Paredes, B. Clotet, C. Brander, 2018, Mucosal Immunology.

Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients

J. Mallolas, M. Laguno, J. Navarro, 2017, The Journal of antimicrobial chemotherapy.

Removal from liver transplantation list of a hepatitis C virus‐HIV co‐infected patient after successful treatment with sofosbuvir and daclatasvir

M. Crespo, J. Esteban, R. Esteban, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Bacterial pneumonia in HIV‐infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome

A. Ferrer, A. Curran, V. Falcó, 2008, HIV medicine.

Darunavir and Ritonavir Total and Unbound Plasmatic Concentrations in HIV-HCV-Coinfected Patients with Hepatic Cirrhosis Compared to Those in HIV-Monoinfected Patients

J. Navarro, A. Curran, J. Burgos, 2015, Antimicrobial Agents and Chemotherapy.

Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis.

B. Clotet, J. Mallolas, M. Crespo, 2012, The Journal of infection.

Assessing main death pathways in T lymphocytes from HIV infected individuals

B. Clotet, J. Martinez-Picado, E. Negredo, 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.

I. Molina, F. Salvador, J. Navarro, 2013, The American journal of tropical medicine and hygiene.

Pharmacokinetic interaction between nevirapine and rifampicin in HIV-infected patients with tuberculosis.

I. Ocaña, E. Ribera, V. Falcó, 2001, Journal of acquired immune deficiency syndromes.

Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy

D. Podzamczer, J. Gatell, E. Martinez, 2012, AIDS.

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus.

J. Mallolas, M. Crespo, C. Quereda, 2011, The Journal of antimicrobial chemotherapy.

Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group.

J. Zamora, J. Navarro, M. Crespo, 2017, Enfermedades infecciosas y microbiologia clinica.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

F. Vidal, E. Ribera, M. Crespo, 2008, The Journal of antimicrobial chemotherapy.

Invasive Pneumococcal Disease in HIV-Infected Adults: Clinical Changes After the Introduction of the Pneumococcal Conjugate Vaccine in Children

J. Navarro, A. Curran, J. Burgos, 2012, Journal of acquired immune deficiency syndromes.

Simpliﬁcation to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients

D. Podzamczer, J. Navarro, A. Curran, 2012 .

Concomitant nevirapine therapy is associated with higher efficacy of pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients.

C. Tural, M. Laguno, M. Crespo, 2010 .

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

D. Podzamczer, C. Vidal, B. Rodés, 2020, AIDS Research and Therapy.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection

C. Delaugerre, D. Costagliola, Y. Lévy, 2020, Annals of Internal Medicine.

Efficacy and Safety of Once-Daily Combination Therapy with Didanosine, Lamivudine and Nevirapine in Antiretroviral-Naive HIV-Infected Patients

J. Miro, J. Blanco, I. Ocaña, 2005, Antiviral therapy.

Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics

M. Crespo, A. Rivero, M. Vivancos, 2016, Open forum infectious diseases.

Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection

M. Buti, M. Crespo, C. Cantarell, 2014, PloS one.

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

E. Negredo, E. Martinez, J. De La Torre, 2021, The Journal of antimicrobial chemotherapy.

Changes in Body Composition and Mitochondrial Dna in HIV-1-Infected Patients Switching to Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine: A Substudy of the Bicombo Trial

D. Podzamczer, J. Gatell, E. Martinez, 2012, Antiviral therapy.

Improvements in Subcutaneous Fat, Lipid Profile, and Parameters of Mitochondrial Toxicity in Patients with Peripheral Lipoatrophy When Stavudine is Switched to Tenofovir (LIPOTEST Study)

S. Sauleda, E. García-Arumí, A. Curran, 2008, HIV clinical trials.

Genotypic resistance in HIV-infected naive patients receiving abacavir plus lamivudine and efavirenz.

D. Podzamczer, J. Gatell, J. Niubó, 2007, Journal of acquired immune deficiency syndromes.

Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study.

V. Falcó, M. Crespo, M. Cruz, 2006, Vaccine.

A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques

J. Mullins, N. Sardesai, B. Clotet, 2015, Journal of Translational Medicine.

Costs and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

J. Gatell, E. Martinez, J. De La Torre, 2018, Enfermedades infecciosas y microbiologia clinica.

Costs and cost-efficacy analysis of the 2016 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

J. Gatell, J. De La Torre, M. Crespo, 2017, Enfermedades infecciosas y microbiologia clinica.

Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients.

C. Riera, I. Molina, A. Curran, 2007, The Journal of antimicrobial chemotherapy.

HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain

M. Buti, R. Girones, J. Rodriguez-Manzano, 2012, HIV medicine.

Peginterferon alpha‐2b plus ribavirin vs interferon alpha‐2b plus ribavirin for chronic hepatitis C in HIV‐coinfected patients

M. Buti, S. Sauleda, I. Ocaña, 2007, Journal of viral hepatitis.

Lactic acidosis related to nucleoside therapy in HIV-infected patients

E. Ribera, V. Falcó, M. Crespo, 2003, Expert opinion on pharmacotherapy.

Increased expression of SAMHD1 in a subset of HIV-1 elite controllers.

B. Clotet, C. Brander, M. Permanyer, 2014, The Journal of antimicrobial chemotherapy.

Cell Cycle Control and HIV-1 Susceptibility Are Linked by CDK6-Dependent CDK2 Phosphorylation of SAMHD1 in Myeloid and Lymphoid Cells

B. Clotet, C. Brander, Mar Alvarez, 2014, The Journal of Immunology.

Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.

J. Navarro, A. Curran, J. Burgos, 2014, AIDS patient care and STDs.

Efficacy, safety and pharmacokinetics of 900/100 mg of darunavir/ritonavir once daily in treatment-experienced patients.

A. Curran, E. Ribera, M. Crespo, 2010, The Journal of antimicrobial chemotherapy.

Abacavir Coadministration Does Not Interfere with the Suppressive Activity of Ribavirin in An HCV Replicon System

A. Curran, E. Ribera, V. Falcó, 2011, Antiviral therapy.

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)

M. Crespo, C. Quereda, A. Avellón, 2019, Scientific Reports.

Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.

A. Curran, E. Ribera, V. Falcó, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Utility of week-4 viral response to tailor treatment duration in hepatitis C virus genotype 3/HIV co-infected patients

M. Buti, S. Sauleda, E. Ribera, 2007, AIDS.

Atazanavir and lopinavir/ritonavir: pharmacokinetics, safety and efficacy of a promising double-boosted protease inhibitor regimen

A. Curran, I. Ocaña, E. Ribera, 2006, AIDS.

Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.

A. Curran, I. Ocaña, E. Ribera, 2007, The Journal of antimicrobial chemotherapy.

Sofosbuvir and daclatasvir in mono- and HIV-coinfected patients with recurrent hepatitis C after liver transplant.

I. Bilbao, M. Crespo, J. Esteban, 2017, Annals of hepatology.

Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.

D. Podzamczer, J. Gatell, J. Mallolas, 2015, The Lancet. Infectious diseases.

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients

D. Podzamczer, C. Tural, M. Crespo, 2010, AIDS.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Steady-State Pharmacokinetics of a Double-Boosting Regimen of Saquinavir Soft Gel plus Lopinavir plus Minidose Ritonavir in Human Immunodeficiency Virus-Infected Adults

B. Clotet, L. Ruiz, I. Ocaña, 2004, Antimicrobial Agents and Chemotherapy.

Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection

R. Paredes, B. Clotet, C. Brander, 2018, Mucosal Immunology.

Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue

J. Martinez-Picado, J. Navarro, M. Crespo, 2017, PloS one.

Phosphorylation of SAMHD1 in Myeloid and Are Linked by CDK6-Dependent CDK2 Cell Cycle Control and HIV-1 Susceptibility

Mar Alvarez, L. Menéndez-Arias, F. Posas, 2014 .

Host genetic associations with the gut microbiota in HIV-1-infected subjects: a pilot exploratory study

R. Paredes, B. Clotet, E. Negredo, 2018, bioRxiv.

Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells

M. Nielsen, C. Brander, P. Borrow, 2015, European journal of immunology.

Switching From a Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen: A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy–suppressed Human Immunodeficiency Virus–infected Individuals

J. Martinez-Picado, J. Blanco, L. Vandekerckhove, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up

T. Pumarola, J. Miro, J. Gatell, 2011, Journal of NeuroVirology.

Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients.

C. Riera, I. Molina, F. Salvador, 2013, The American journal of tropical medicine and hygiene.

Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides.

M. Crespo, J. Gavaldà, A. Pahissa, 2003, The Journal of antimicrobial chemotherapy.

Gut Microbiota Linked to Sexual Preference and HIV Infection

P. Bork, F. Guarner, F. Hildebrand, 2016, EBioMedicine.

The effectiveness of electrocautery ablation for the treatment of high‐grade anal intraepithelial neoplasia in HIV‐infected men who have sex with men

S. Landolfi, J. Navarro, A. Curran, 2016, HIV medicine.

Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers

R. Paredes, À. Olvera, C. Brander, 2018, Journal of Virology.

Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial

J. Navarro, A. Curran, J. Burgos, 2020, Journal of clinical medicine.

Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM

S. Landolfi, J. Navarro, A. Curran, 2015, AIDS.

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

I. Martínez, M. Salavert, E. Ribera, 2019, Scientific Reports.

Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen.

M. Crespo, J. Esteban, J. Pineda, 2008, The Journal of antimicrobial chemotherapy.

Acute Leg Ischaemia in an HIV-Infected Patient Receiving Antiretroviral Treatment

J. Navarro, A. Curran, J. Burgos, 2016, Antiviral therapy.

Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy.

B. Clotet, J. Martinez-Picado, L. Montaner, 2016, The Journal of infectious diseases.

Long-Term Effectiveness of First-Line Antiretroviral Theraphy in a Cohort of HIV-1 Infected Patients

A. Curran, J. Burgos, I. Ocaña, 2012 .

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Impact of Low-Level Viraemia on Virological Failure in HIV-1-Infected Patients with Stable Antiretroviral Treatment

J. Navarro, A. Curran, J. Burgos, 2016, Antiviral therapy.

Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group.

D. Podzamczer, E. Martinez, A. Curran, 2014, The Journal of antimicrobial chemotherapy.

HIV-HCV Co-Infected Patients with Hepatic Cirrhosis Compared to HIV 2

J. Navarro, A. Curran, J. Burgos, 2015 .

CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study

M. Crespo, A. Terrón, F. Gutiérrez, 2014, Journal of the International AIDS Society.

A Case of Multiorgan Failure Following Interruption of Antiretroviral Treatment

I. Ocaña, V. Falcó, M. Crespo, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Sofosbuvir and Daclatasvir in Mono- and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant.

I. Bilbao, M. Crespo, L. Castells, 2017, Annals of hepatology.

Epidemiology and Long-Term Survival in HIV-Infected Patients With Pneumocystis jirovecii Pneumonia in the HAART Era

L. Miguel, J. Navarro, A. Curran, 2015, Medicine.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2019, The Journal of antimicrobial chemotherapy.

Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine: 96-Week Results of a Randomized Study

D. Podzamczer, J. Gatell, J. Niubó, 2007, Journal of acquired immune deficiency syndromes.

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

D. Podzamczer, B. Clotet, J. Gatell, 2015, Enfermedades Infecciosas y Microbiologia Clinica.

Memory B cell dysregulation in HIV-1-infected individuals

B. Clotet, E. Negredo, M. Massanella, 2017, AIDS.

Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.

C. Tural, J. Mallolas, M. Crespo, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy

D. Podzamczer, J. Gatell, J. Mallolas, 2016, HIV clinical trials.

Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis

M. Crespo, C. Quereda, J. Bellón, 2014, Journal of acquired immune deficiency syndromes.

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients

M. Muñoz-Fernández, M. Crespo, C. Quereda, 2018, AIDS.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

J. M. García de Lomas, J. De La Torre, E. Ribera, 2019, The Journal of antimicrobial chemotherapy.

Simplification to dual antiretroviral therapy including a ritonavir-boosted protease inhibitor in treatment-experienced HIV-1-infected patients.

Manuel Crespo, D. Podzamczer, J. Navarro, 2012, The Journal of antimicrobial chemotherapy.

Darunavir and telaprevir drug interaction: total and unbound plasma concentrations in HIV/HCV-coinfected patients with cirrhosis.

A. Curran, E. Ribera, M. Crespo, 2014, The Journal of antimicrobial chemotherapy.

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status

M. Crespo, C. Quereda, S. Resino, 2018, Cells.

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

J. De La Torre, J. Prada, S. Reus, 2018, The Journal of antimicrobial chemotherapy.

Raltegravir, Etravirine, and Ritonavir-Boosted Darunavir: A Safe and Successful Rescue Regimen for Multidrug-Resistant HIV-1 Infection

A. Curran, E. Ribera, V. Falcó, 2009, Journal of acquired immune deficiency syndromes.

Early Monitoring of Ribavirin Serum Concentration is not Useful to Optimize Hepatitis C Virus treatment in HIV-Coinfected Patients

S. Sauleda, A. Curran, E. Ribera, 2007, Antiviral therapy.

Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapine

D. Podzamczer, J. Gatell, E. Ribera, 2005, AIDS.

Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV‐coinfected patients

S. Pérez-Hoyos, J. Navarro, A. Curran, 2015, HIV medicine.

Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen.

D. Podzamczer, A. Curran, J. Burgos, 2012, The Journal of antimicrobial chemotherapy.

Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital

J. Navarro, A. Curran, J. Burgos, 2013, HIV medicine.

Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48‐week analysis of results from the PROTEST study

R. Paredes, D. Podzamczer, E. Poveda, 2017, HIV medicine.

Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients

J. Andreu, V. Falcó, M. Crespo, 2003, European Radiology.

Efficacy of recombinant interleukin-2 (rIL-2) in patients with advanced HIV-1 infection and blunted immune response to HAART.

I. Caragol, E. Ribera, V. Falcó, 2008, Enfermedades infecciosas y microbiologia clinica.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

F. Vidal, E. Ribera, M. Crespo, 2008, The Journal of antimicrobial chemotherapy.

Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.

M. Crespo, C. Quereda, J. Bellón, 2015, Annals of hepatology.

Association of baseline CD 4 + cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV / HCV coinfected patients

M. Crespo, C. Quereda, J. Bellón, 2015 .

Effectiveness of Efavirenz Compared with Ritonavir-Boosted Protease-Inhibitor-Based Regimens as Initial Therapy for Patients with Plasma HIV-1 RNA above 100,000 Copies/Ml

D. Podzamczer, B. Clotet, J. Navarro, 2014, Antiviral therapy.